Wei Pan
Impact in
- Health Informatics top 5%
- Biological Psychiatry top 10%
Papers in
-
- Gut microbiota and health 7
- RNA modifications and cancer 6
- Immunology 21
- Immune Response and Inflammation 4
- Immune cells in cancer 4
- Co-authors
- Menglong Wang (31 shared papers)Jishou Zhang (30 shared papers)Jun Wan (29 shared papers)Shujie Liao (6 shared papers)Xu Yao (2 shared papers)Hong Jiang (2 shared papers)Yuehan Li (3 shared papers)Yao Xu (26 shared papers)
- Journals
- Heliyon (4 papers)PLoS ONE (3 papers)Biochemical Pharmacology (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Frontiers in Cardiovascular Medicine (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Pan
119 papers receiving 3.0k citations
Wei Pan's Hit Papers
Peers
Comparison fields: 5 of 165
- Health Informatics 33
- Biological Psychiatry 49
- Immunology 378
- Cancer Research 220
- Neurology 120
Countries citing papers authored by Wei Pan
This map shows the geographic impact of Wei Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Pan more than expected).
Fields of papers citing papers by Wei Pan
This network shows the impact of papers produced by Wei Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Pan. The network helps show where Wei Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human papillomavirus vaccine against cervical cancer: Opportunity and challenge Hit paper breakdown → | 2019 | 323 |
| 2 | Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases Hit paper breakdown → | 2022 | 311 |
| 3 | 2019 | 141 | |
| 4 | 2018 | 115 | |
| 5 | 2022 | 87 | |
| 6 | 2011 | 81 | |
| 7 | 2016 | 67 | |
| 8 | 2018 | 63 | |
| 9 | 2020 | 60 | |
| 10 | 2023 | 55 | |
| 11 | 2022 | 53 | |
| 12 | 2015 | 53 | |
| 13 | 2019 | 51 | |
| 14 | 2021 | 51 | |
| 15 | 2020 | 50 | |
| 16 | 2020 | 49 | |
| 17 | 2021 | 47 | |
| 18 | 2023 | 46 | |
| 19 | 2017 | 42 | |
| 20 | Serological survey of nasopharyngeal carcinoma in 21 cities of south China. | 1995 | 37 |
About Wei Pan
Wei Pan is a scholar working on Molecular Biology, Immunology, Surgery, Oncology and Cardiology and Cardiovascular Medicine, having authored 125 papers that have together received 3.0k indexed citations. Recurring topics across this work include Gut microbiota and health (7 papers), RNA modifications and cancer (6 papers), COVID-19 Clinical Research Studies (5 papers), Cardiac Fibrosis and Remodeling (5 papers), Long-Term Effects of COVID-19 (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Immune Response and Inflammation (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Health Informatics (33 citations), Biological Psychiatry (49 citations), Immunology (378 citations), Cancer Research (220 citations) and Neurology (120 citations). Wei Pan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Menglong Wang, Jishou Zhang, Jun Wan, Shujie Liao, Xu Yao, Hong Jiang, Yuehan Li, Yao Xu, Mengmeng Zhao and Wei‐Ming Huang. Their work appears in journals such as Heliyon, PLoS ONE, Biochemical Pharmacology, Bioorganic & Medicinal Chemistry Letters and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.